GENERATE BIOMEDICINES INC
Q1 2026 13F Holders
Symbol
GENB
CUSIP
370920100
Type
Equity
Class
COM SHS
Num filings
58
Total reported value, excl. options
$1.16 B
Compare 2026 Q1 to
2026 Q3
2026 Q2
Manager
Report Date
Value ($000)
Shares
Option Type